Impaired endothelium-dependent vasodilator response in patients with pulmonary fibrosis

Respiratory Medicine

Volumn 107, Issue 2, 2013, Pages 269-275

  Aihara, Kensaku ^a   Handa, Tomohiro ^a,b   Nagai, Sonoko ^c   Tanizawa, Kiminobu ^a   Ikezoe, Kohei ^a   Watanabe, Kizuku ^a   Chihara, Yuichi ^a   Harada, Yuka ^a   Yoshimura, Chikara ^a   Oga, Toru ^a   Ozasa, Neiko ^a   Uno, Kazuko ^d   Chin, Kazuo ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c Clinical Research Center   (Japan)

^d Louis Pasteur Center for Medical Research   (Japan)

Author keywords

Digital pulse amplitude tonometry; Endothelial function; Pulmonary fibrosis; Reactive hyperemia

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGE DISTRIBUTION; AGED; AMPLITUDE MODULATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARBON MONOXIDE BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIGITAL PULSE AMPLITUDE TONOMETRY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPEREMIA; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS OXYGEN TENSION; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; OXYGEN SATURATION; PRIORITY JOURNAL; PULSE RATE; REACTIVE HYPEREMIA INDEX; SEX RATIO; TONOMETRY; VASCULAR ENDOTHELIUM; VASODILATATION; WALKING;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARBON DIOXIDE; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FEMALE; HUMANS; HYPEREMIA; INFLAMMATION MEDIATORS; LIPIDS; MALE; MANOMETRY; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; PULMONARY FIBROSIS; TOMOGRAPHY, X-RAY COMPUTED; VASODILATION;

EID: 84872114469     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.10.005     Document Type: Article

References (34)

1. R.B. Hubbard, C. Smith, I. Le Jeune, J. Gribbin, and A.W. Fogarty The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study Am J Respir Crit Care Med 178 2008 1257 1261
2. A. Ponnuswamy, R. Manikandan, A. Sabetpour, I.M. Keeping, and J.P. Finnerty Association between ischaemic heart disease and interstitial lung disease: a case-control study Respir Med 103 2009 503 507
3. G. Izbicki, I. Ben-Dor, D. Shitrit, D. Bendayan, T.K. Aldrich, and R. Kornowski The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor? Respir Med 103 2009 1346 1349
4. S.D. Nathan, A. Basavaraj, C. Reichner, O.A. Shlobin, S. Ahmad, and J. Kiernan Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis Respir Med 104 2010 1035 1041
5. R.J. Panos, R.L. Mortenson, S.A. Niccoli, and T.E. King Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment Am J Med 88 1990 396 404
6. K. Hamada, S. Nagai, S. Tanaka, T. Handa, M. Shigematsu, and T. Nagao Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis Chest 131 2007 650 656
7. T.A. Wynn Integrating mechanisms of pulmonary fibrosis J Exp Med 208 2011 1339 1350
8. M.W. Ziegenhagen, P. Zabel, G. Zissel, M. Schlaak, and J. Muller-Quernheim Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity Am J Respir Crit Care Med 157 1998 762 768
9. A. Nakao, Y. Hasegawa, Y. Tsuchiya, and K. Shimokata Expression of cell adhesion molecules in the lungs of patients with idiopathic pulmonary fibrosis Chest 108 1995 233 239
10. A. Tedgui, and Z. Mallat Cytokines in atherosclerosis: pathogenic and regulatory pathways Physiol Rev 86 2006 515 581
11. R.C. Chambers Role of coagulation cascade proteases in lung repair and fibrosis Eur Respir J Suppl 44 2003 33s 35s
12. D.V. Faller Endothelial cell responses to hypoxic stress Clin Exp Pharmacol Physiol 26 1999 74 84
13. M.E. Widlansky, N. Gokce, J.F. Keaney Jr., and J.A. Vita The clinical implications of endothelial dysfunction J Am Coll Cardiol 42 2003 1149 1160
14. Y. Matsuzawa, S. Sugiyama, K. Sugamura, T. Nozaki, K. Ohba, and M. Konishi Digital assessment of endothelial function and ischemic heart disease in women J Am Coll Cardiol 55 2010 1688 1696
15. N.M. Hamburg, and E.J. Benjamin Assessment of endothelial function using digital pulse amplitude tonometry Trends Cardiovasc Med 19 2009 6 11
16. G. Raghu, H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, and K.K. Brown An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
17. ATS statement guidelines for the six-minute walk test Am J Respir Crit Care Med 166 2002 111 117
18. H. Kokkonen, I. Soderstrom, J. Rocklov, G. Hallmans, K. Lejon, and S. Rantapaa Dahlqvist Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis Arthritis Rheum 62 2010 383 391
19. E.A. Kazerooni, F.J. Martinez, A. Flint, D.A. Jamadar, B.H. Gross, and D.L. Spizarny Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring AJR Am J Roentgenol 169 1997 977 983
20. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 2002 277 304
21. T. Suvorava, N. Lauer, and G. Kojda Physical inactivity causes endothelial dysfunction in healthy young mice J Am Coll Cardiol 44 2004 1320 1327
22. L. Ostergaard, E. Stankevicius, M.R. Andersen, Y. Eskildsen-Helmond, T. Ledet, and M.J. Mulvany Diminished NO release in chronic hypoxic human endothelial cells Am J Physiol Heart Circ Physiol 293 2007 H2894 H2903
23. S. Kinlay, D. Behrendt, M. Wainstein, J. Beltrame, J.C. Fang, and M.A. Creager Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries Circulation 104 2001 1114 1118
24. V.J. Dzau Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis Hypertension 37 2001 1047 1052
25. H.P. Kohler, and P.J. Grant Plasminogen-activator inhibitor type 1 and coronary artery disease N Engl J Med 342 2000 1792 1801
26. S.H. Park, D. Saleh, A. Giaid, and R.P. Michel Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist Am J Respir Crit Care Med 156 1997 600 608
27. M. Otsuka, H. Takahashi, M. Shiratori, H. Chiba, and S. Abe Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax 59 2004 31 38
28. T. Senoo, N. Hattori, T. Tanimoto, M. Furonaka, N. Ishikawa, and K. Fujitaka Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis Thorax 65 2010 334 340
29. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
30. R.B. Low, K.B. Adler, J. Woodcock-Mitchell, M.S. Giancola, and P.M. Vacek Bronchoalveolar lavage lipids during development of bleomycin-induced fibrosis in rats. Relationship to altered epithelial cell morphology Am Rev Respir Dis 138 1988 709 713
31. P.C. Robinson, L.C. Watters, T.E. King, and R.J. Mason Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids Am Rev Respir Dis 137 1988 585 591
32. E. Fireman, S. Spitzer, J. Grief, S. Kivity, and M. Topilsky Cholesterol crystals in BAL fluid from patients with idiopathic pulmonary fibrosis Respir Med 90 1996 361 363
33. L.H. Lancaster, W.R. Mason, J.A. Parnell, T.W. Rice, J.E. Loyd, and A.P. Milstone Obstructive sleep apnea is common in idiopathic pulmonary fibrosis Chest 136 2009 772 778
34. J. Li, V. Savransky, A. Nanayakkara, P.L. Smith, C.P. O'Donnell, and V.Y. Polotsky Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia J Appl Physiol 102 2007 557 563